Immutep
Search :
Corporate Information
Product Development
Clinical Trials
Business Strategy
Investor Relations
Contact Us
News
May 26, 2013
Topics:
Corporate Information
Product Development
Clinical Trials
Business Strategy
Investor Relations
Contact Us
News
>
Page bottom
Home
»
News
»
Interview Frederic Triebel with PharmaTelevision
Interview Frederic Triebel with PharmaTelevision
Get the Flash Player
to see this video.
Published 02/2012 by
admin@immutep.com
© 2002 Immutep, S.A.
Press Release
04/2012 -
Immutep and Lonza Sign Agreement for Cell Line Selection, Cell Banking and Process Development of ImmuFact® IMP321
Immutep and Lonza announced today an agreement for cell line ...
02/2012 -
Interview Frederic Triebel with PharmaTelevision
Get the Flash ...
01/2011 -
Immutep and GlaxoSmithKline sign licence agreement for IMP731, a novel therapeutic antibody for the treatment of autoimmune diseases
Immutep S.A. announced today the execution of a licence agreement ...
09/2010 -
Immutep announces final results in phase I/II chemoimmunotherapy trial in metastatic breast cancer.
Clinical research paper describes IMP321’s potency in achieving ...
05/2010 -
Immutep Announces Oral Presentation at ASCO Annual Meeting of IMP321 Final Results In Phase I/II Chemoimmunotherapy Trial
Immutep S.A. announced today that the final results from its Phase ...